OECD Expert Meeting on eHealth Indicators

empiricaBoth the European Union and the World Health Organisation (WHO) have recognised ICT-facilitated solutions as key enablers for modern, patient-centered and efficient healthcare services. To support health policies, it has become mandatory to monitor and benchmark Health ICT (eHealth) adoption and use. This is also a priority topic for EU/USA cooperation in the field of eHealth. The OECD plans to coordinate global activities, including involvement of WHO, to develop appropriate approaches and measuring tools.

empirica's director Werner B. Korte and eHealth expert Dr. Veli N. Stroetmann were invited to participate in an OECD expert meeting on May 25 on measuring the progress of global eHealth diffusion. Currently, indicators on eHealth availability and use are not uniform, and do not cover all OECD countries. The European Commission funded empirica studies on eHealth Indicators and eHealth Benchmarking compiled a comprehensive inventory of available statistical evidence on eHealth in Europe, Canada and the USA. This research also developed an indicator framework to support and guide the development of and agreement on a comprehensive set of key global indicators and procedures for data gathering on eHealth. Furthermore, detailed policy recommendations were drafted to take the work on indicators forward. Werner B. Korte and Veli Stroetmann presented the results of these studies at the OECD meeting in Paris and discussed together with other country and OECD/WHO experts and policy makers how to harmonise key global indicators, including how best to coordinate national and European surveys to comparatively measure eHealth progress.

"empirica is proud to have its long standing expertise in eHealth as well as indicator development, monitoring and benchmarking recognised at the level of the OECD and will continue to monitor and assess the eHealth landscape in Europe," concluded Werner B. Korte.

For further information, please visit:

Related news articles:

About empirica
empirica Communication and Technology Research is a private research institute founded in 1976 and based in Bonn, Germany. It specialises in communication and information technology related research and consultancy to clients in both the private and public sector. Its body of expertise ranges from long-term RTD roadmapping, policy and strategy development to pilot trials and EU-wide representative market research. The company has gained a strong profile in the practical development, pilot-testing and market validation of IST-based healthcare services. It observes and interprets market trends and evaluates the socio-economic impact of eHealth applications. In addition, it regularly conducts foresight exercises, representative surveys and compiles data bases of good practice case studies with the support of a dense network of contacts in government, industry and academia. For further information, please visit www.empirica.com.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...